Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH

Adams, 2007, Nonalcoholic fatty liver disease, Ann Epidemiol, 17, 863, 10.1016/j.annepidem.2007.05.013 Nseir, 2014, Role of diet and lifestyle changes in nonalcoholic fatty liver disease, World J Gastroenterol, 20, 9338 Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466 Fazel, 2016, Epidemiology and natural history of non-alcoholic fatty liver disease, Metabolism, 65, 1017, 10.1016/j.metabol.2016.01.012 Reccia, 2017, Non-alcoholic fatty liver disease: a sign of systemic disease, Metabolism, 72, 94, 10.1016/j.metabol.2017.04.011 Silverman, 1990, Liver pathology in morbidly obese patients with and without diabetes, Am J Gastroenterol, 85, 1349 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterol, 116, 1413, 10.1016/S0016-5085(99)70506-8 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Brunt, 2015, Nonalcoholic fatty liver disease, Nat Rev Dis Primers, 1, 15080, 10.1038/nrdp.2015.80 Lefkowitch, 2002, Kupffer cell aggregation and perivenular distribution in steatohepatitis, Modern Pathol, 15, 699, 10.1097/01.MP.0000019579.30842.96 Carpino, 2005, Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 37, 349, 10.1016/j.dld.2004.11.009 Polyzos, 2010, The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease, Diabetes Obes Metab, 2, 365, 10.1111/j.1463-1326.2009.01176.x Baffy, 2009, Kupffer cells in non-alcoholic fatty liver disease: the emerging view, J of Hepatology, 51, 212, 10.1016/j.jhep.2009.03.008 Bray, 2013, Calorie-sweetened beverages and fructose: what have we learned 10 years later, Pediatr Obes, 8, 242, 10.1111/j.2047-6310.2013.00171.x Fujii, 2012, Inflammation and fibrogenesis in steatohepatitis, J Gastroenterol, 47, 215, 10.1007/s00535-012-0527-x Carpino, 2013, Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks, Int J of Mol Sci, 14, 20112, 10.3390/ijms141020112 Boutari, 2018, Association of adipokines with development and progression of nonalcoholic fatty liver disease, Endocrinol Metabol, 33, 33, 10.3803/EnM.2018.33.1.33 Sferra, 2017, The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study, Eur J of Histochem, 61, 2732, 10.4081/ejh.2017.2732 Vetuschi, 2014, Features of intestinal lesions in the clinical course of inflammatory bowel diseases, Ital J Anat Embryol, 119, 286 Lobello, 2009, High-fat diet and the risk for non-alcoholic fatty liver disease: a population-based study, Dig Liver Dis, 41, A1, 10.1016/j.dld.2008.12.008 Nakamura, 2013, Lessons from mouse models of high-fat diet-induced NAFLD, Int J Mol Sci, 14, 21240, 10.3390/ijms141121240 Tessitore, 2017, Development of Hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model, Oncotarget, 8, 53482, 10.18632/oncotarget.18585 Acosta-Cota, 2018, Histopathological and biochemical changes in the development of non-alcoholic fatty liver disease induced by high sucrose diet at different times, Can J Physiol Pharmacol, 97, 23, 10.1139/cjpp-2018-0353 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Bedossa, 2012, Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, 56, 1751, 10.1002/hep.25889 Nobili, 2012, Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease, Hepatol, 56, 2142, 10.1002/hep.25742 Sferra, 2018, Interaction between sphingosine kinase/sphingosine 1 phosphate and transforming growth factor-β/Smads pathways in experimental intestinal fibrosis. An in vivo immunohistochemical study, Eur J Histochem, 1, 62 Karim, 2015, Non-alcoholic fatty liver disease (NAFLD)—a review, MMJ, 24, 873 Papandreou, 2015, Role of diet on non-alcoholic fatty liver disease: an updated narrative review, World J Hepatol, 3, 575, 10.4254/wjh.v7.i3.575 Parvin, 2017, Relationship between diet and non-alcoholic fatty liver disease: a review article, Iran J Public Health, 46, 1007 Xie, 2010, Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat, Metabolism, 59, 554, 10.1016/j.metabol.2009.08.022 Nakamuta, 2008, The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease, Int J Mol Med, 22, 663 Capanni, 2006, Prolonged N-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study, Aliment Pharmacol Ther, 23, 1143, 10.1111/j.1365-2036.2006.02885.x Ali, 2009, Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome, J Hepatol, 51, 918, 10.1016/j.jhep.2009.05.033 Nimer, 2008, Soft drink consumption linked with fatty liver in the absence of traditional risk factors, Can J Gastroenterol, 22, 811, 10.1155/2008/810961 Neuschwander-Tetri, 2013, Carbohydrate intake and nonalcoholic fatty liver disease, Curr Opin Clin Nutr Metab Care, 16, 446, 10.1097/MCO.0b013e328361c4d1 Parks, 2008, Dietary sugars stimulate fatty acid synthesis in adults, J Nutr, 138, 1039, 10.1093/jn/138.6.1039 Cox, 2009, Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans, J Clin Invest, 119, 1322, 10.1172/JCI37385 Lê, 2009, Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes, Am J Clin Nutr, 89, 1760, 10.3945/ajcn.2008.27336 Bergheim, 2008, Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin, J Hepatol, 48, 983, 10.1016/j.jhep.2008.01.035 Kawasaki, 2009, Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis, J Nutr, 139, 2067, 10.3945/jn.109.105858 Vos, 2013, Dietary fructose in nonalcoholic fatty liver disease, Hepatology, 57, 2525, 10.1002/hep.26299 Jensen, 2018, Fructose and sugar: a major mediator of non-alcoholic fatty liver disease, J Hepatol, 68, 1063, 10.1016/j.jhep.2018.01.019 Di Nicolantoni, 2017, Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis, Open Heart, 4 Cahova, 2012, The opposite effects of high-sucrose and high-fat diet on fatty acid oxidation and very low density lipoprotein secretion in rat model of metabolic syndrome, J Nutr Metab, 2012, 10.1155/2012/757205 Fernandes-Lima, 2015, Short exposure to a high-sucrose diet and the first ‘hit’ of nonalcoholic fatty liver disease in mice, Cells Tissues Organs, 201, 464, 10.1159/000446514 Poggi, 2011, CD40L Deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice, Arterioscler Thromb Vasc Biol, 31, 2251, 10.1161/ATVBAHA.111.231357 Itagaki, 2013, Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice, Int J Clin Exp Pathol, 6, 2683 Polyzos, 2019, Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics, Metabolism, 92, 82, 10.1016/j.metabol.2018.11.014 Rico, 2005, Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance, Endocrinology, 146, 4167, 10.1210/en.2005-0156 Lloret, 2019, Obesity as a risk factor for Alzheimer's disease: implication of leptin and glutamate, Front Neurosci, 13, 508, 10.3389/fnins.2019.00508 Cappariello, 2016, The “soft” side of the bone: unveiling its endocrine functions, Horm Mol Biol Clin Invest, 28, 5 Takeda, 2002, Leptin regulates bone formation via the sympathetic nervous system, Cell, 111, 305, 10.1016/S0092-8674(02)01049-8 Zhang, 2000, Ceiling culture of mature human adipocytes: use in studies of adipocyte functions, J Endocrinol, 164, 119, 10.1677/joe.0.1640119 Velickovic, 2018, Low temperature exposure induces browning of bone marrow stem cell derived adipocytes in vitro, Sci Rep, 8, 4974, 10.1038/s41598-018-23267-9 Oliveira, 2001, Leptin and leptin receptor mRNA are widely expressed in tumors of adipocytic differentiation, Mod Pathol, 14, 549, 10.1038/modpathol.3880349 Kim, 2015, Cytoplasmic and nuclear leptin expression in lacrimal gland tumours: a pilot study, Br J Ophthalmol, 99, 1306, 10.1136/bjophthalmol-2014-306404 Farag, 2016, Immunohistochemical expression of leptin in non melanoma skin cancer, J Clin Diagn Res, 10, WC08 Potter, 1998, Transdifferentiation of rat hepatic stellate cells results in leptin expression, Biochem Biophys Res Commun, 6, 178, 10.1006/bbrc.1997.8193 Zhai, 2017, Leptin reduces microRNA-122 level in hepatic stellate cells in vitro and in vivo, Mol Immunol, 92, 68, 10.1016/j.molimm.2017.10.006